1753. Adherence and Immunogenicity of Early Vaccination in Pediatric Allogeneic Hematopoietic Cell Transplantation (allo-HCT) Recipients

BACKGROUND: Allo-HCT recipients are at increased risk for vaccine-preventable infections. Early vaccination (EV) beginning at 3–6 months (mo) post-HCT has been shown to be safe, immunogenic, and is recommended. We assessed adherence and immunogenicity to EV in children post-allo-HCT. METHODS: Retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Danino, Dana, Stanek, Joseph, Skeens, Micah, Rangarajan, Hemalatha, Ardura, Monica I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809012/
http://dx.doi.org/10.1093/ofid/ofz360.1616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809012/
http://dx.doi.org/10.1093/ofid/ofz360.1616

Ejemplares similares